《半新股》華營建築(01582.HK)急彈26%曾高見1.13元 成交倍增
港股今天窄幅爭持,部分資金流向追捧半新股,其中本港樓宇建築總承建商--華營建築(01582.HK)上市第五天,股價昨日曾挫30%至0.66元,三連吐,今天最多急彈近47%高見1.13元,重越上市價1元,現造0.97元,急彈26%,成交環比急增逾2倍至2,577萬股。
同以每股1元上市第五天的本港環境衛生服務供應商--莊臣控股(01955.HK)繼首日掛牌飆升逾倍至2.16元遇阻,收市僅升23%後,股價同樣連跌三日,今早進一步低見0.92元獲承接,之後掉頭高見1.07元,現造1.01元,回升5.2%,重越上市價,成交增至1,463萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.